eConsent Solutions
-
Technology Solutions And Services Tailored For Emerging Biopharma
1/16/2024
Explore how this collection of solutions and services is transforming clinical trials and empowering emerging biopharma organizations to revolutionize medicine.
-
eConsent For Clinical Trials
6/4/2025
Help your patients make informed decisions without burying them in paper
With electronic informed consent (eConsent) software, your patients can access consent forms using any device they choose. And because it’s part of TrialKit’s unified platform, both your patients and your study team get a seamless experience.
-
EDC: Control Your Data, Control Your Study
2/16/2023
Streamline data, maximize efficiencies, tighten up costs, and reach end goals faster using Medrio’s powerful and intuitive EDC tool.
-
Improving The Patient Experience With Total Consent
11/6/2023
Increased outreach, heightened involvement, superior quality. Tour this comprehensive consent management solution that enhances participant access and improves the overall patient experience.
-
Improving Trial Efficiency With eClinical Solutions
10/24/2023
Clinical development organizations looking for efficient, expedient, and agile technology solutions should see how leveraging an eClinical suite with unified solutions and a single database can drive efficiency.
-
Empower Patients To Make Informed Decisions
11/8/2022
YPrime’s eConsent platform and patient-centered approach ensure better comprehension of complex information, accelerate enrollment and screening, and improve patient engagement.
-
Optimizing The Path To RSV Vaccine Approval
2/20/2024
Vaccine trials pose unique challenges; that's why sponsors and CROs trust us to navigate complexities and capture audit-ready, high-quality evidence required to get new vaccines to patients.
-
Hybrid eConsent: Remote And On-Site
3/21/2025
Studies show when participants are informed and comfortable with the consent process, they're more likely to comply with protocol, remain enrolled, and contribute to faster study deployment.